Skip to main content

Table 5 Comparison of quality of life after intervention between group A and group B (x±s)

From: Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosis

Group

Group A (34)

Group B (34)

P

Physical health

42.00±6.86

48.60±6.50

<0.001

Mental health

68.15±7.18

79.58±7.30

<0.001

Material life

65.31±5.18

78.23±6.02

<0.001

Social function

62.40±4.30

69.20±5.00

<0.001